Year of publication
Type of media
Type of material
Licence
Language
1–20 of 285 hits
Sort by:
Sort by:
-
A case of eosinophilic bronchiolitis after the initiation of immune checkpoint inhibitor
Free accessWiley | 2023|Keywords: atezolizumab -
A case of HCC successfully treated with infliximab‐steroid sequential therapy for small bowel perforation due to atezolizumab/bevacizumab combination therapy
Free accessWiley | 2022|Keywords: atezolizumab -
A Case of Immune-Related Aseptic Meningitis during Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma
Free accessKarger Verlag | 2024|Keywords: Atezolizumab -
A case of severe acute hemorrhagic duodenitis after administration of immune checkpoint inhibitor
Free accessWiley | 2022|Keywords: atezolizumab -
Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study
Free accessKarger Verlag | 2023|Keywords: Atezolizumab plus bevacizumab -
Acid-induced aggregation propensity of nivolumab is dependent on the Fc
Free accessTaylor & Francis Verlag | 2016|Keywords: atezolizumab -
A clinical variable‐based nomogram could predict the survival for advanced NSCLC patients receiving second‐line atezolizumab
Free accessWiley | 2021|Keywords: atezolizumab -
Acute tubulointerstitial nephritis associated with atezolizumab, an anti-programmed death-ligand 1 (pd-l1) antibody therapy
Free accessTaylor & Francis Verlag | 2018|Keywords: atezolizumab -
Adjuvant Atezolizumab-Bevacizumab after Resection or Ablation for Hepatocellular Carcinoma
Free accessKarger Verlag | 2023|Keywords: Atezolizumab plus bevacizumab -
Adjuvant atezolizumab in Japanese patients with resected stage IB‐IIIA non‐small cell lung cancer (IMpower010)
Free accessWiley | 2022|Keywords: atezolizumab -
A drug safety evaluation of atezolizumab in locally advanced or metastatic urothelial carcinoma
Taylor & Francis Verlag | 2020|Keywords: atezolizumab -
Adverse cutaneous toxicities by PD-1/PD-L1 immune checkpoint inhibitors: pathogenesis, treatment, and surveillance
Taylor & Francis Verlag | 2022|Keywords: atezolizumab -
Adverse events as potential predictive factors of therapeutic activity in patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab
Free accessWiley | 2023|Keywords: atezolizumab plus bevacizumab -
A history of variceal bleeding is associated with further bleeding under atezolizumab–bevacizumab in patients with HCC
Wiley | 2022|Keywords: atezolizumab‐bevacizumab -
Albumin-Bilirubin Grade Analyses of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: A Post Hoc Analysis of the Phase III IMbrave150 Study
Free accessKarger Verlag | 2023|Keywords: Atezolizumab -
All Stages of Hepatocellular Carcinoma Patients Benefit from Systemic Therapy Combined with Locoregional Therapy
Free accessKarger Verlag | 2023|Keywords: Atezolizumab plus bevacizumab -
Alternative dosing regimens for atezolizumab: an example of model-informed drug development in the postmarketing setting
Free accessOnline Contents | 2019|Keywords: Atezolizumab -
Alternative dosing regimens for atezolizumab: right dose, wrong frequency
Online Contents | 2019|Keywords: Atezolizumab -
Anaphylactic shock in a small cell lung cancer patient receiving atezolizumab therapy: a rare but potentially fatal complication
Online Contents | 2021|Keywords: Atezolizumab -
A non-linear association between blood tumor mutation burden and prognosis in NSCLC patients receiving atezolizumab
Free accessTaylor & Francis Verlag | 2020|Keywords: atezolizumab
Send my search to (beta)
Send your search query (search terms without filters) to other databases, portals and catalogues to find more interesting hits.
Dimensions:
full data search
or
title and abstract search
Dimensions is a database for abstracts and citations that links information on research funding with the resulting publications, studies and patents.
TIB AV portal
In the TIB AV-Portal, audiovisual media from science and teaching can be foundand own scientific videos can be published.
Specialised Information Service for Mobility and Transport Research (FID move)
Open Research Knowledge Graph (ORKG)
The FID move can be used to search for subject-specific literature, research data and other information from mobility and transport research.
The Open Research Knowledge Graph provides structured descriptions of research content and makes it comparable.
Common Union Catalogue (GVK)
Freely accessible part of the collaborative K10plus catalogue with materials relevant for interlibrary loan and direct delivery services.